LH
Laboratory Corporation of America Holdings
NYSE: LH · HEALTHCARE · DIAGNOSTICS & RESEARCH
$257.14
-0.94% today
Updated 2026-04-29
Market cap
$21.19B
P/E ratio
24.56
P/S ratio
1.52x
EPS (TTM)
$10.47
Dividend yield
1.11%
52W range
$237 – $292
Volume
0.6M
Laboratory Corporation of America Holdings (LH) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $632.30M | $709.70M | $780.90M | $862.40M | $883.60M | $855.60M | $841.40M | $818.70M | $739.00M | $982.40M | $1.18B | $1.46B | $1.31B | $1.44B | $2.14B | $3.11B | $1.96B | $1.33B | $1.59B | $1.64B |
| Capital expenditures | $116.50M | $143.30M | $156.70M | $114.70M | $126.50M | $145.70M | $176.30M | $202.20M | $203.50M | $255.80M | $278.90M | $315.40M | $379.80M | $400.20M | $381.70M | $460.40M | $481.90M | $453.60M | $489.90M | $434.50M |
| Depreciation | $155.00M | $162.80M | $179.70M | $195.10M | $203.60M | $231.40M | $229.80M | $230.10M | $245.50M | $457.80M | $499.20M | $533.20M | $552.10M | $577.20M | $624.70M | $745.10M | $633.90M | $577.30M | $643.50M | $681.10M |
| Stock-based comp | $52.70M | $-8.40M | $36.20M | $36.40M | $40.00M | $48.90M | $40.70M | $37.30M | $45.70M | $102.10M | $109.60M | $109.70M | $91.60M | $107.00M | $111.70M | $153.70M | $144.10M | $128.70M | $116.70M | $125.80M |
| Free cash flow | $515.80M | $566.40M | $624.20M | $747.70M | $757.10M | $709.90M | $665.10M | $616.50M | $535.50M | $726.60M | $897.00M | $1.14B | $925.60M | $1.04B | $1.75B | $2.65B | $1.47B | $874.10M | $1.10B | $1.21B |
| Investing cash flow | $-273.30M | $-341.50M | $-396.00M | $-334.00M | $-1.32B | $-280.30M | $-534.20M | $-359.60M | $-350.10M | $-3.99B | $-795.70M | $-2.23B | $206.70M | $-1.28B | $-643.20M | $-884.60M | $-1.65B | $-1.17B | $-1.37B | $-1.19B |
| Financing cash flow | $-353.50M | $-363.70M | $-218.50M | $-600.90M | $515.30M | $-645.00M | $-800000.00 | $-518.30M | $-200.60M | $3.18B | $-649.80M | $631.90M | $-1.39B | $-252.70M | $-517.40M | $-2.07B | $-1.32B | $-59.30M | $779.90M | $-1.46B |
| Dividends paid | — | — | $370.90M | $592.70M | $551.20M | $1.38B | $1.30B | $1.11B | $1.20M | $0.00 | $139.50M | $3.34B | $467.20M | $2.40B | $151.70M | $1.00B | $195.20M | $254.00M | $243.10M | $240.70M |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | $-71.20M | $82.20M | $-71.40M | $307.50M | $-62.80M | $176.00M | $136.40M | $-282.80M | $-116.90M | $110.20M | — | — | — | — | — | — | — |